NCT04890093 2026-03-16Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1/2 Suspended64 enrolled